Unknown

Dataset Information

Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.


ABSTRACT: Dysregulated Notch signaling has been implicated in numerous human diseases, including a broad spectrum of cancers. Mutations in Notch1 are prevalent in T-cell acute lymphoblastic leukemia, and abnormal expression of different human Notch receptors contributes to B-cell tumors as well as cancers of the breast, lung, pancreas, skin, prostate, colon, brain and other tissues. Several γ-secretase inhibitors, small chemical compounds that were initially developed to inhibit the activity of the γ-secretase aspartyl protease in Alzheimer's disease, are now being explored for their potential chemotherapeutic applications in Notch-associated cancers. An alternative approach involves the development of antibodies to inhibit specific Notch receptors, their activating ligands, or other components of t

SUBMITTER: Groth C 

PROVIDER: S-EPMC3372654 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature